About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials in Chicago | 193 Studies

Clinical Trials SchizophreniaChicago

Schizophrenia Clinical Trials in Chicago

Find 193 clinical trials for schizophrenia near Chicago, Illinois. Connect with research centers in your area.

All Schizophrenia trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 193 trials

CompletedAn Extension Study to Assess Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-4)This is a Phase 3, multicenter, 53-week, outpatient, open-label extension (OLE) study to evaluate the long-term safety, tolerability, and efficacy of KarXT in subjects with…NCT04659174·Bentonville, Arkansas and 43 others

Schizophrenia Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedMedication Adherence in Schizophrenia: Development of a CBT-Based InterventionThis is a randomized pilot study of an intervention based on principles of Cognitive Behavioral Therapy (CBT).NCT00980252·Chicago, Illinois

TerminatedLong-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)This is a study of ABT-126 in the treatment of cognitive impairment associated with schizophrenia (CIAS), a long-term extension study to study M10-855 (NCT01655680).NCT01834638·Chino, California and 50 others

CompletedSwitching to Iloperidone From Other Antipsychotics in SchizophreniaEvaluate the clinical outcome of two switching strategies to iloperidone treatment in adult subjects with schizophrenia who require a change in their current antipsychotic…NCT01207414·Birmingham, Alabama and 58 others

CompletedPharmacokinetics of Understudied Drugs Administered to Children Per Standard of CareUnderstudied drugs will be administered to children per standard of care as prescribed by their treating caregiver and only biological sample collection during the time of drug…NCT01431326·Anchorage, Alaska and 51 others

CompletedOlanzapine Versus Placebo in the Treatment of Adolescents With SchizophreniaThis study is to determine the efficacy (how well the drug works), safety, and any side effects of olanzapine compared to placebo in the treatment of schizophrenia in adolescents.NCT00051298·Little Rock, Arkansas and 24 others

CompletedA Study to Assess the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adults With Schizophrenia or Bipolar Disorder Treated With Antipsychotic MedicationsThis phase 2, double blind, placebo-controlled, randomized study is to assess the safety, efficacy, and pharmacokinetics (PK) of miricorilant (CORT118335) in obese adults with…NCT03818256·Bentonville, Arkansas and 26 others

TerminatedEfficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant SchizophreniaThis study evaluates the efficacy of 10 mg/day Lu AF35700 on symptoms of schizophrenia in patients with early-in-disease (ED) or late-in-disease (LD) treatment-resistant…NCT03230864·San Diego, California and 40 others

CompletedAn Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable SchizophreniaThis study will evaluate the safety, tolerability, and pharmacokinetics (PK) of various doses and dosing intervals of aripiprazole lauroxil.NCT02320032·Little Rock, Arkansas and 15 others

CompletedA Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective DisorderThis Phase IV, randomized, parallel-group study is designed to evaluate the cataractogenic potential of quetiapine fumarate (SEROQUEL) compared with that of a putative…NCT00206102·Little Rock, Arkansas and 62 others

TerminatedOculomotor and Spatial Cognition Deficits in SchizophreniaDESCRIPTION: (Verbatim from the Applicant's Abstract) Abnormalities of eye movement control and spatial cognition are well-established deficits in schizophrenia.NCT00931996·Chicago, Illinois

CompletedOpen-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective DisorderThis is a long-term, open-label clinical study designed to enable longer-term treatment of patients completing other clinical studies with intramuscular olanzapine depot.NCT00088465·Orange, California and 91 others

CompletedTreatment of Social Cognition in Schizophrenia TrialThis study is a multi-site, prospective, parallel arm, double-blind, randomized, controlled clinical trial to assess the efficacy of an experimental software program targeting…NCT02246426·Los Angeles, California and 3 others

CompletedAn Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of SchizophreniaThis is a Phase 3, multicenter, 52-week, outpatient, open-label extension (OLE) study to evaluate the long-term safety and tolerability of adjunctive KarXT in subjects with…NCT05304767·Phoenix, Arizona and 93 others

RecruitingCLOZAPINE Response in Biotype-1The CLOZAPINE study is designed as a multisite study across 5 sites and is a clinical trial, involving human participants who are prospectively assigned to an intervention.NCT04580134·Hartford, Connecticut and 4 others

CompletedQuetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Adolescent Patients With SchizophreniaThe purpose of this study is to demonstrate efficacy and safety of quetiapine fumarate (SEROQUEL) compared with placebo in the treatment of adolescent patients with schizophrenia.NCT00090324·Dothan, Alabama and 41 others

CompletedA Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With SchizophreniaThe primary objective of this study is to evaluate the long term safety and tolerability of ALKS 3831 in subjects with schizophrenia.NCT02669758·Little Rock, Arkansas and 30 others

CompletedA Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in SchizophreniaThis is a safety and efficacy study evaluating a experimental treatment for cognitive deficits in adults with schizophrenia.NCT01655680·Anaheim, California and 60 others

CompletedEfficacy and Safety Study for Cognitive Deficits in Adult Subjects With SchizophreniaThis is an efficacy and safety study evaluating an experimental treatment for cognitive deficits in adults with schizophrenia.NCT01077700·Anaheim, California and 23 others

CompletedComparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase SchizophrenicsThe goal of this project is to show that the best possible option for preventing relapses in patients suffering from first episode (\<1 year of anti-psychotic medication) or early…NCT02360319·Tucson, Arizona and 38 others

PreviousPage 3 of 10Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia